Applications of Gene Therapy - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 318

[257] Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Good
pasture's syndrome, and type IV collagen. N Engl J Med 2003;348:2543-56.
[258] Heikkila P, Parpala T, Lukkarinen O, Weber M, Tryggvason K. Adenovirus-mediated
gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion sys-
tem—first steps toward gene of Alport syndrome. Gene Ther 1996;3:21-7.
[259] Heikkila P, Tibell A, Morita T, Chen Y, Wu G, Sado Y, et al. Adenovirus-mediated trans-
fer of type IV collagen alpha5 chain cDNA into swine kidney in vivo : deposition of the
protein into the glomerular basement membrane. Gene Ther 2001;8:882-90.
[260] Zhu G, Nicolson AG, Cowley BD, Rosen S, Sukhatme VP. In vivo adenovirus mediated
gene transfer into normal & cystic rat kidneys. Gene Ther 1996;3:298-304.
[261] Ricker J, Mata J, Iversen P, Gatton V. C-myc antisense oligonucleotide treatment ame-
liorates murine ARPKD. Kidney Int 2002;61:S125-31.
[262] Lai LW, Chan DM, Erickson RP, Hsu SJ, Lien YH. Correction of renal tubular acidosis
in carbonic anhydrase II-deficient mice with gene therapy. J Clin Invest 1998;101:
1320-5.
[263] Schonberg T, Sandig V, Wess J, Gudermann T, Schultz G. Reconstitution of mutant V2
vasopressin receptors by adenovirus mediated gene transfer: molecular basis and clini-
cal implication. J Clin Invest 1997;100:1547-56.
[264] Akagi Y, Isaka Y, Arai M, Kaneko T, Takenaka M, Moriyama T, et al. Inhibition of
TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix
accumulation in experimental glomerulonephritis. Kidney Int 1996;50:148-55.
[265] Carl M, Akagi Y, Weidner S, Isaka Y, Imai E, Rupprecht HD. Specific inhibition of
Egr-1 prevents mesangial cell hypercellularity in experimental nephritis. Kidney Int
2003;63:1302-12.
[266] Isaka Y, Tsujie M, Ando Y, Nakamura H, Kaneda Y, Imai E, et al. Transforming growth
factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ure-
teral obstruction. Kidney Int 2000;58:1885-92.
[267] Maeshima Y, Kashihara N, Yasuda T, Sugiyama H, Sekikawa T, Okamoto K, et al.
Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro
and in vivo . J Clin Invest 1998;101:2589-97.
[268] Tomita N, Morishita R, Tomita S, Gibbons GH, Zhang L, Horiuchi M, et al.
Transcription factor decoy for NF kappa B inhibits TNF-alpha-induced cytokine and
adhesion molecule expression in vivo . Gene Ther 2000;7:1326-32.
[269] Nakamura H, Isaka Y, Tsujie M, Rupprecht HD, Akagi Y, Ueda N, et al. Introduction
of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced
interstitial alpha-smooth muscle actin expression and fibrosis in unilateral ureteral
obstruction (UUO) rats. Gene Ther 2002;9:495-502.
[270] Isaka Y, Brees DK, Ikegaya K, Kaneda Y, Imai E, Noble NA, et al. Gene therapy by
skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med
1996;2:418-23.
[271] Isaka Y, Akagi Y, Ando Y, Tsujie M, Sudo T, Ohno N, et al. Gene therapy by transform-
ing growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accu-
mulation in experimental glomerulonephritis. Kidney Int 1999;55:465-75.
[272] Choi Y, Kim Y, Park H, Choi K, Paik S, Lee Y, et al. Suppression of glomerulosclerosis
by adenovirus-mediated IL-10 expression in the kidney. Gene Ther 2003:559-68.
[273] Munger KA, Montero A, Fukunaga M, Uda S, Yura T, Imai E, et al. Transfection of
rat kidney with human 15-lipoxygenase suppresses inflammation and preserves
function in experimental glomerulonephritis. Proc Natl Acad Sci USA 1999;96:
13375-80.